These cells were injected with three different concentrations of STZ (0.5, 1, 2 mM) to induce Alzheimer’s disease by affecting insulin resistance and these concentrations were based on the amount reported by Bagaméry et al.‏8. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.